Advertisement

Index by Author

September 1997; 20 (9)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abbasi, F

    • Adherence of Mononuclear Cells to Endothelium In Vitro Is Increased in Patients With NIDDM Diabetes Care September 1997 20:1462-1465; doi:10.2337/diacare.20.9.1462

  2. Amemiya, Shin

    • Role of IGF Binding Protein- 1 in the Dawn Phenomenon and Glycemic Control in Children and Adolescents With IDDM Diabetes Care September 1997 20:1442-1447; doi:10.2337/diacare.20.9.1442

  3. Arakaki, Richard F

    • The Insulin Resistance Syndrome in Native Hawaiians Diabetes Care September 1997 20:1376-1380; doi:10.2337/diacare.20.9.1376

  4. Atherosclerosis risk in Communities (ARIC) Study Investigators

    • Glycosylated Hemoglobin Level and Carotid Intimal-Medial Thickening in Nondiabetic Individuals: The Atherosclerosis Risk in Communities Study Diabetes Care September 1997 20:1454-1458; doi:10.2337/diacare.20.9.1454

  5. Atkinson, A Brew

    • Treatment of Diabetic Ketoacidosis Using Normalization of Blood 3-Hydroxybutyrate Concentration as the Endpoint of Emergency Management: A randomized controlled study Diabetes Care September 1997 20:1347-1352; doi:10.2337/diacare.20.9.1347

B

  1. Bagriaçik, Nazif

    • Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment Diabetes Care September 1997 20:1353-1356; doi:10.2337/diacare.20.9.1353

  2. Barzilay, Joshua I

    • Coronary Artery Disease in Diabetic Patients With Lower-Extremity Arterial Disease: Disease Characteristics and Survival: A report from the Coronary Artery Surgery Study (CASS) registry Diabetes Care September 1997 20:1381-1387; doi:10.2337/diacare.20.9.1381

  3. Bates, David J

    • Power Spectral Analysis of Heart Rate Variability in Children and Adolescents With IDDM Diabetes Care September 1997 20:1416-1421; doi:10.2337/diacare.20.9.1416

  4. Bayén, L

    • Lack of Change of Lipoprotein(a) Levels by the Optimization of Glycemic Control With Insulin Therapy in NIDDM Patients Diabetes Care September 1997 20:1459-1461; doi:10.2337/diacare.20.9.1459

  5. Beléndez, Marina

    • Effects of a Behavioral Intervention on Treatment Adherence and Stress Management in Adolescents With IDDM Diabetes Care September 1997 20:1370-1375; doi:10.2337/diacare.20.9.1370

  6. Bell, Patrick M

    • Treatment of Diabetic Ketoacidosis Using Normalization of Blood 3-Hydroxybutyrate Concentration as the Endpoint of Emergency Management: A randomized controlled study Diabetes Care September 1997 20:1347-1352; doi:10.2337/diacare.20.9.1347

  7. Bittner, Vera

    • Coronary Artery Disease in Diabetic Patients With Lower-Extremity Arterial Disease: Disease Characteristics and Survival: A report from the Coronary Artery Surgery Study (CASS) registry Diabetes Care September 1997 20:1381-1387; doi:10.2337/diacare.20.9.1381

  8. Bloomgarden, Zachary T

    • Topics in Type 2 Diabetes Diabetes Care September 1997 20:1487-1490; doi:10.2337/diacare.20.9.1487

  9. Boden, Guenther

    • Longitudinal Study of Carbohydrate Metabolism in Healthy Obese Pregnant Women Diabetes Care September 1997 20:1470-1475; doi:10.2337/diacare.20.9.1470

  10. Bonet, Rosa

    • Lack of Change of Lipoprotein(a) Levels by the Optimization of Glycemic Control With Insulin Therapy in NIDDM Patients Diabetes Care September 1997 20:1459-1461; doi:10.2337/diacare.20.9.1459

  11. Boyko, Edward J

    • Evidence That Plasma Leptin and Insulin Levels are Associated With Body Adiposity Via Different Mechanisms Diabetes Care September 1997 20:1476-1481; doi:10.2337/diacare.20.9.1476

  12. Boyle, Douglas I

    • ACE Inhibitor Use Is Associated With Hospitalization for Severe Hypoglycemia in Patients With Diabetes Diabetes Care September 1997 20:1363-1367; doi:10.2337/diacare.20.9.1363

  13. Brancati, Frederick L

    • Glycosylated Hemoglobin Level and Carotid Intimal-Medial Thickening in Nondiabetic Individuals: The Atherosclerosis Risk in Communities Study Diabetes Care September 1997 20:1454-1458; doi:10.2337/diacare.20.9.1454

  14. Bril, Vera

    • Comparison of a Neurothesiometer and Vibration in Measuring Vibration Perception Thresholds and Relationship to Nerve Conduction Studies Diabetes Care September 1997 20:1360-1362; doi:10.2337/diacare.20.9.1360

  15. Byrne, G C

    • The Use of Biothesiometry to Detect Neuropathy in Children and Adolescents With IDDM Diabetes Care September 1997 20:1448-1453; doi:10.2337/diacare.20.9.1448

C

  1. Caixàs, Assumpta

    • Lack of Change of Lipoprotein(a) Levels by the Optimization of Glycemic Control With Insulin Therapy in NIDDM Patients Diabetes Care September 1997 20:1459-1461; doi:10.2337/diacare.20.9.1459

  2. Carantoni, M

    • Adherence of Mononuclear Cells to Endothelium In Vitro Is Increased in Patients With NIDDM Diabetes Care September 1997 20:1462-1465; doi:10.2337/diacare.20.9.1462

  3. Castellví, Agustina

    • Lack of Change of Lipoprotein(a) Levels by the Optimization of Glycemic Control With Insulin Therapy in NIDDM Patients Diabetes Care September 1997 20:1459-1461; doi:10.2337/diacare.20.9.1459

  4. Caulfield, Laura E

    • The Epidemiology of Diabetes in Pregnant Native Canadians: A risk profile Diabetes Care September 1997 20:1422-1425; doi:10.2337/diacare.20.9.1422

  5. Cerasi, Erol

    • Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment Diabetes Care September 1997 20:1353-1356; doi:10.2337/diacare.20.9.1353

  6. Chang, Healani K

    • The Insulin Resistance Syndrome in Native Hawaiians Diabetes Care September 1997 20:1376-1380; doi:10.2337/diacare.20.9.1376

  7. Chen, Xinhua

    • Longitudinal Study of Carbohydrate Metabolism in Healthy Obese Pregnant Women Diabetes Care September 1997 20:1470-1475; doi:10.2337/diacare.20.9.1470

  8. Chen, Y-D I

    • Adherence of Mononuclear Cells to Endothelium In Vitro Is Increased in Patients With NIDDM Diabetes Care September 1997 20:1462-1465; doi:10.2337/diacare.20.9.1462

  9. Chu, L

    • Adherence of Mononuclear Cells to Endothelium In Vitro Is Increased in Patients With NIDDM Diabetes Care September 1997 20:1462-1465; doi:10.2337/diacare.20.9.1462

  10. Chusney, Gary D

    • Higher Serum Sialic Acid in Women Than in Men With NIDDM: Possible Relevance to Increased Cardiovascular Risk in NIDDM Women Diabetes Care September 1997 20:1496; doi:10.2337/diacare.20.9.1496

  11. Clark, Kelly

    • Comparison of a Neurothesiometer and Vibration in Measuring Vibration Perception Thresholds and Relationship to Nerve Conduction Studies Diabetes Care September 1997 20:1360-1362; doi:10.2337/diacare.20.9.1360

  12. Colby, Chris J

    • Excess Costs of Medical Care for Patients With Diabetes in a Managed Care Population Diabetes Care September 1997 20:1396-1402; doi:10.2337/diacare.20.9.1396

  13. Cooke, J P

    • Adherence of Mononuclear Cells to Endothelium In Vitro Is Increased in Patients With NIDDM Diabetes Care September 1997 20:1462-1465; doi:10.2337/diacare.20.9.1462

  14. Couper, Jennifer J

    • Power Spectral Analysis of Heart Rate Variability in Children and Adolescents With IDDM Diabetes Care September 1997 20:1416-1421; doi:10.2337/diacare.20.9.1416

  15. Cupples, L Adrienne

    • NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study Diabetes Care September 1997 20:1388-1395; doi:10.2337/diacare.20.9.1388

  16. Curb, J David

    • The Insulin Resistance Syndrome in Native Hawaiians Diabetes Care September 1997 20:1376-1380; doi:10.2337/diacare.20.9.1376

D

  1. D'Agostino, Ralph B

    • NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study Diabetes Care September 1997 20:1388-1395; doi:10.2337/diacare.20.9.1388

  2. Davis, E A

    • The Use of Biothesiometry to Detect Neuropathy in Children and Adolescents With IDDM Diabetes Care September 1997 20:1448-1453; doi:10.2337/diacare.20.9.1448

  3. Davis, Timothy ME

    • U.K. Prospective Diabetes Study 22: Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM Diabetes Care September 1997 20:1435-1441; doi:10.2337/diacare.20.9.1435

E

  1. Eaker, Elaine

    • Coronary Artery Disease in Diabetic Patients With Lower-Extremity Arterial Disease: Disease Characteristics and Survival: A report from the Coronary Artery Surgery Study (CASS) registry Diabetes Care September 1997 20:1381-1387; doi:10.2337/diacare.20.9.1381

  2. Eckfeldt, John H

    • Glycosylated Hemoglobin Level and Carotid Intimal-Medial Thickening in Nondiabetic Individuals: The Atherosclerosis Risk in Communities Study Diabetes Care September 1997 20:1454-1458; doi:10.2337/diacare.20.9.1454

  3. Eijk, J T M Van

    • The Efficacy of Self-Monitoring of Blood Glucose in NIDDM subjects: A criteria-based literature review Diabetes Care September 1997 20:1482-1486; doi:10.2337/diacare.20.9.1482

  4. Elias, Merrill F

    • NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study Diabetes Care September 1997 20:1388-1395; doi:10.2337/diacare.20.9.1388

  5. Elias, Penelope K

    • NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study Diabetes Care September 1997 20:1388-1395; doi:10.2337/diacare.20.9.1388

  6. Evans, Campbell

    • Coronary Artery Disease in Diabetic Patients With Lower-Extremity Arterial Disease: Disease Characteristics and Survival: A report from the Coronary Artery Surgery Study (CASS) registry Diabetes Care September 1997 20:1381-1387; doi:10.2337/diacare.20.9.1381

  7. Evans, Josie M.M

    • ACE Inhibitor Use Is Associated With Hospitalization for Severe Hypoglycemia in Patients With Diabetes Diabetes Care September 1997 20:1363-1367; doi:10.2337/diacare.20.9.1363

F

  1. Faas, A

    • The Efficacy of Self-Monitoring of Blood Glucose in NIDDM subjects: A criteria-based literature review Diabetes Care September 1997 20:1482-1486; doi:10.2337/diacare.20.9.1482

  2. Feeney, Sandra J

    • Evaluation of ICA512As in Combination With Other Islet Cell Autoantibodies at the Onset of IDDM Diabetes Care September 1997 20:1403-1407; doi:10.2337/diacare.20.9.1403

  3. Fischer, Sabine

    • Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM Diabetes Care September 1997 20:1430-1434; doi:10.2337/diacare.20.9.1430

  4. Folsom, Aaron R

    • Glycosylated Hemoglobin Level and Carotid Intimal-Medial Thickening in Nondiabetic Individuals: The Atherosclerosis Risk in Communities Study Diabetes Care September 1997 20:1454-1458; doi:10.2337/diacare.20.9.1454

  5. Foster, Eric D

    • Coronary Artery Disease in Diabetic Patients With Lower-Extremity Arterial Disease: Disease Characteristics and Survival: A report from the Coronary Artery Surgery Study (CASS) registry Diabetes Care September 1997 20:1381-1387; doi:10.2337/diacare.20.9.1381

  6. Fox, Charles J

    • U.K. Prospective Diabetes Study 22: Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM Diabetes Care September 1997 20:1435-1441; doi:10.2337/diacare.20.9.1435

  7. Fuçker, Katja

    • Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM Diabetes Care September 1997 20:1430-1434; doi:10.2337/diacare.20.9.1430

  8. Fujisawa, Hiroki

    • Effects of Glycemic Control on Plasma 3-Deoxyglucosone Levels in NIDDM Patients Diabetes Care September 1997 20:1466-1469; doi:10.2337/diacare.20.9.1466

G

  1. Gao, X Joe

    • Serum Immunoreactive Leptin Concentrations in a Canadian Aboriginal Population With High Rates of NIDDM Diabetes Care September 1997 20:1408-1415; doi:10.2337/diacare.20.9.1408

  2. Glaser, Benjamin

    • Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment Diabetes Care September 1997 20:1353-1356; doi:10.2337/diacare.20.9.1353

  3. Grandinetti, Andrew

    • The Insulin Resistance Syndrome in Native Hawaiians Diabetes Care September 1997 20:1376-1380; doi:10.2337/diacare.20.9.1376

  4. Grispigni, Crispino

    • Involvement of the Musculotendinous Apparatus in Flexion Contractures of Limited Joint Mobility of the Diabetic Hand Diabetes Care September 1997 20:1493-1495; doi:10.2337/diacare.20.9.1493

H

  1. Hadden, David R

    • Treatment of Diabetic Ketoacidosis Using Normalization of Blood 3-Hydroxybutyrate Concentration as the Endpoint of Emergency Management: A randomized controlled study Diabetes Care September 1997 20:1347-1352; doi:10.2337/diacare.20.9.1347

  2. Haffner, Steven M

    • Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM Diabetes Care September 1997 20:1430-1434; doi:10.2337/diacare.20.9.1430

  3. Hamada, Yoji

    • Effects of Glycemic Control on Plasma 3-Deoxyglucosone Levels in NIDDM Patients Diabetes Care September 1997 20:1466-1469; doi:10.2337/diacare.20.9.1466

  4. Hanefeld, Markolf

    • Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM Diabetes Care September 1997 20:1430-1434; doi:10.2337/diacare.20.9.1430

  5. Hanley, Anthony J G

    • Serum Immunoreactive Leptin Concentrations in a Canadian Aboriginal Population With High Rates of NIDDM Diabetes Care September 1997 20:1408-1415; doi:10.2337/diacare.20.9.1408

  6. Harper, Roy

    • Treatment of Diabetic Ketoacidosis Using Normalization of Blood 3-Hydroxybutyrate Concentration as the Endpoint of Emergency Management: A randomized controlled study Diabetes Care September 1997 20:1347-1352; doi:10.2337/diacare.20.9.1347

  7. Harris, Stewart B

    • Serum Immunoreactive Leptin Concentrations in a Canadian Aboriginal Population With High Rates of NIDDM Diabetes Care September 1997 20:1408-1415; doi:10.2337/diacare.20.9.1408
    • The Epidemiology of Diabetes in Pregnant Native Canadians: A risk profile Diabetes Care September 1997 20:1422-1425; doi:10.2337/diacare.20.9.1422

  8. Heiss, Gerardo

    • Glycosylated Hemoglobin Level and Carotid Intimal-Medial Thickening in Nondiabetic Individuals: The Atherosclerosis Risk in Communities Study Diabetes Care September 1997 20:1454-1458; doi:10.2337/diacare.20.9.1454

  9. Henning, Beth

    • The Epidemiology of Diabetes in Pregnant Native Canadians: A risk profile Diabetes Care September 1997 20:1422-1425; doi:10.2337/diacare.20.9.1422

  10. Higashida, Kosuke

    • Role of IGF Binding Protein- 1 in the Dawn Phenomenon and Glycemic Control in Children and Adolescents With IDDM Diabetes Care September 1997 20:1442-1447; doi:10.2337/diacare.20.9.1442

  11. Holman, Rury R

    • U.K. Prospective Diabetes Study 22: Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM Diabetes Care September 1997 20:1435-1441; doi:10.2337/diacare.20.9.1435

  12. Homko, Carol J

    • Longitudinal Study of Carbohydrate Metabolism in Healthy Obese Pregnant Women Diabetes Care September 1997 20:1470-1475; doi:10.2337/diacare.20.9.1470

  13. Hotta, Nlgishi

    • Effects of Glycemic Control on Plasma 3-Deoxyglucosone Levels in NIDDM Patients Diabetes Care September 1997 20:1466-1469; doi:10.2337/diacare.20.9.1466

  14. Howard, Neville

    • Evaluation of ICA512As in Combination With Other Islet Cell Autoantibodies at the Onset of IDDM Diabetes Care September 1997 20:1403-1407; doi:10.2337/diacare.20.9.1403

  15. Hozumi, Toshiki

    • Insulin Responses to Oral Glucose During 4-Year Treatment With Nifedipine Retard in Hypertensive Patients With and Without NIDDM Diabetes Care September 1997 20:1491; doi:10.2337/diacare.20.9.1491a

I

  1. Ilkova, Hasan

    • Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment Diabetes Care September 1997 20:1353-1356; doi:10.2337/diacare.20.9.1353

  2. Ishida, Yoshihiko

    • Insulin Responses to Oral Glucose During 4-Year Treatment With Nifedipine Retard in Hypertensive Patients With and Without NIDDM Diabetes Care September 1997 20:1491; doi:10.2337/diacare.20.9.1491a

  3. Ishihara, Toshihide

    • Role of IGF Binding Protein- 1 in the Dawn Phenomenon and Glycemic Control in Children and Adolescents With IDDM Diabetes Care September 1997 20:1442-1447; doi:10.2337/diacare.20.9.1442

J

  1. Jones, T W

    • The Use of Biothesiometry to Detect Neuropathy in Children and Adolescents With IDDM Diabetes Care September 1997 20:1448-1453; doi:10.2337/diacare.20.9.1448

  2. Jung, Roland T

    • ACE Inhibitor Use Is Associated With Hospitalization for Severe Hypoglycemia in Patients With Diabetes Diabetes Care September 1997 20:1363-1367; doi:10.2337/diacare.20.9.1363

K

  1. Kahn, Steven E

    • Evidence That Plasma Leptin and Insulin Levels are Associated With Body Adiposity Via Different Mechanisms Diabetes Care September 1997 20:1476-1481; doi:10.2337/diacare.20.9.1476

  2. Kato, Kiyohiko

    • Role of IGF Binding Protein- 1 in the Dawn Phenomenon and Glycemic Control in Children and Adolescents With IDDM Diabetes Care September 1997 20:1442-1447; doi:10.2337/diacare.20.9.1442

  3. Kazumi, Tsutomu

    • Insulin Responses to Oral Glucose During 4-Year Treatment With Nifedipine Retard in Hypertensive Patients With and Without NIDDM Diabetes Care September 1997 20:1491; doi:10.2337/diacare.20.9.1491a

  4. Kehely, Anne M

    • Higher Serum Sialic Acid in Women Than in Men With NIDDM: Possible Relevance to Increased Cardiovascular Risk in NIDDM Women Diabetes Care September 1997 20:1496; doi:10.2337/diacare.20.9.1496

  5. Kinney, Everett K

    • The Insulin Resistance Syndrome in Native Hawaiians Diabetes Care September 1997 20:1376-1380; doi:10.2337/diacare.20.9.1376

  6. Kobayashi, Kisho

    • Role of IGF Binding Protein- 1 in the Dawn Phenomenon and Glycemic Control in Children and Adolescents With IDDM Diabetes Care September 1997 20:1442-1447; doi:10.2337/diacare.20.9.1442

  7. Kobayashi, Koji

    • Role of IGF Binding Protein- 1 in the Dawn Phenomenon and Glycemic Control in Children and Adolescents With IDDM Diabetes Care September 1997 20:1442-1447; doi:10.2337/diacare.20.9.1442

  8. Koh, Naoki

    • Effects of Glycemic Control on Plasma 3-Deoxyglucosone Levels in NIDDM Patients Diabetes Care September 1997 20:1466-1469; doi:10.2337/diacare.20.9.1466

  9. Kojic, Jasna

    • Comparison of a Neurothesiometer and Vibration in Measuring Vibration Perception Thresholds and Relationship to Nerve Conduction Studies Diabetes Care September 1997 20:1360-1362; doi:10.2337/diacare.20.9.1360

  10. Kronmal, Richard A

    • Coronary Artery Disease in Diabetic Patients With Lower-Extremity Arterial Disease: Disease Characteristics and Survival: A report from the Coronary Artery Surgery Study (CASS) registry Diabetes Care September 1997 20:1381-1387; doi:10.2337/diacare.20.9.1381

  11. Kumar, Dinesh

    • Lispro Analog for Treatment of Generalized Allergy to Human Insulin Diabetes Care September 1997 20:1357-1359; doi:10.2337/diacare.20.9.1357

  12. Kwan, Jeremy

    • Serum Immunoreactive Leptin Concentrations in a Canadian Aboriginal Population With High Rates of NIDDM Diabetes Care September 1997 20:1408-1415; doi:10.2337/diacare.20.9.1408

L

  1. Lao, Terence T

    • Maternal Serum Ferritin and Gestational Impaired Glucose Tolerance Diabetes Care September 1997 20:1368-1369; doi:10.2337/diacare.20.9.1368

  2. LeBlanc, Suzanne M

    • Dermal Interstitial Glucose as an Indicator of Ambient Glycemia Diabetes Care September 1997 20:1426-1429; doi:10.2337/diacare.20.9.1426

  3. Leiva, Alberto De

    • Lack of Change of Lipoprotein(a) Levels by the Optimization of Glycemic Control With Insulin Therapy in NIDDM Patients Diabetes Care September 1997 20:1459-1461; doi:10.2337/diacare.20.9.1459

  4. Leonhardt, Wolfgang

    • Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM Diabetes Care September 1997 20:1430-1434; doi:10.2337/diacare.20.9.1430

M

  1. MacDonald, Thomas M

    • ACE Inhibitor Use Is Associated With Hospitalization for Severe Hypoglycemia in Patients With Diabetes Diabetes Care September 1997 20:1363-1367; doi:10.2337/diacare.20.9.1363

  2. Mackay, Ian R

    • Evaluation of ICA512As in Combination With Other Islet Cell Autoantibodies at the Onset of IDDM Diabetes Care September 1997 20:1403-1407; doi:10.2337/diacare.20.9.1403

  3. Mather, Hugh M

    • Higher Serum Sialic Acid in Women Than in Men With NIDDM: Possible Relevance to Increased Cardiovascular Risk in NIDDM Women Diabetes Care September 1997 20:1496; doi:10.2337/diacare.20.9.1496

  4. Mau, Marjorie K

    • The Insulin Resistance Syndrome in Native Hawaiians Diabetes Care September 1997 20:1376-1380; doi:10.2337/diacare.20.9.1376

  5. McGovern, Paul G

    • Glycosylated Hemoglobin Level and Carotid Intimal-Medial Thickening in Nondiabetic Individuals: The Atherosclerosis Risk in Communities Study Diabetes Care September 1997 20:1454-1458; doi:10.2337/diacare.20.9.1454

  6. McMahon, Alexander D

    • ACE Inhibitor Use Is Associated With Hospitalization for Severe Hypoglycemia in Patients With Diabetes Diabetes Care September 1997 20:1363-1367; doi:10.2337/diacare.20.9.1363

  7. Méndez, Francisco J

    • Effects of a Behavioral Intervention on Treatment Adherence and Stress Management in Adolescents With IDDM Diabetes Care September 1997 20:1370-1375; doi:10.2337/diacare.20.9.1370

  8. Moore, Jason

    • Evidence That Plasma Leptin and Insulin Levels are Associated With Body Adiposity Via Different Mechanisms Diabetes Care September 1997 20:1476-1481; doi:10.2337/diacare.20.9.1476

  9. Morawiecki, Andrew

    • Evidence That Plasma Leptin and Insulin Levels are Associated With Body Adiposity Via Different Mechanisms Diabetes Care September 1997 20:1476-1481; doi:10.2337/diacare.20.9.1476

  10. Morris, Andrew D

    • ACE Inhibitor Use Is Associated With Hospitalization for Severe Hypoglycemia in Patients With Diabetes Diabetes Care September 1997 20:1363-1367; doi:10.2337/diacare.20.9.1363

  11. Myers, Mark A

    • Evaluation of ICA512As in Combination With Other Islet Cell Autoantibodies at the Onset of IDDM Diabetes Care September 1997 20:1403-1407; doi:10.2337/diacare.20.9.1403

N

  1. Nakamura, Jiro

    • Effects of Glycemic Control on Plasma 3-Deoxyglucosone Levels in NIDDM Patients Diabetes Care September 1997 20:1466-1469; doi:10.2337/diacare.20.9.1466

  2. Nakashima, Eltaro

    • Effects of Glycemic Control on Plasma 3-Deoxyglucosone Levels in NIDDM Patients Diabetes Care September 1997 20:1466-1469; doi:10.2337/diacare.20.9.1466

  3. Nakazawa, Shinpei

    • Role of IGF Binding Protein- 1 in the Dawn Phenomenon and Glycemic Control in Children and Adolescents With IDDM Diabetes Care September 1997 20:1442-1447; doi:10.2337/diacare.20.9.1442

  4. Native Hawaiian Health Research (NHHR) Project

    • The Insulin Resistance Syndrome in Native Hawaiians Diabetes Care September 1997 20:1376-1380; doi:10.2337/diacare.20.9.1376

  5. Ness, Sheryl

    • Dermal Interstitial Glucose as an Indicator of Ambient Glycemia Diabetes Care September 1997 20:1426-1429; doi:10.2337/diacare.20.9.1426

  6. Newton, Ray W

    • ACE Inhibitor Use Is Associated With Hospitalization for Severe Hypoglycemia in Patients With Diabetes Diabetes Care September 1997 20:1363-1367; doi:10.2337/diacare.20.9.1363

  7. Ngo, Mylan

    • Comparison of a Neurothesiometer and Vibration in Measuring Vibration Perception Thresholds and Relationship to Nerve Conduction Studies Diabetes Care September 1997 20:1360-1362; doi:10.2337/diacare.20.9.1360

  8. Nicolson, Marjery

    • Evidence That Plasma Leptin and Insulin Levels are Associated With Body Adiposity Via Different Mechanisms Diabetes Care September 1997 20:1476-1481; doi:10.2337/diacare.20.9.1476

O

  1. O'Brien, Peter C

    • Dermal Interstitial Glucose as an Indicator of Ambient Glycemia Diabetes Care September 1997 20:1426-1429; doi:10.2337/diacare.20.9.1426

  2. O'Kane, Maurice J

    • Treatment of Diabetic Ketoacidosis Using Normalization of Blood 3-Hydroxybutyrate Concentration as the Endpoint of Emergency Management: A randomized controlled study Diabetes Care September 1997 20:1347-1352; doi:10.2337/diacare.20.9.1347

P

  1. Parafioriti, Antonina

    • Involvement of the Musculotendinous Apparatus in Flexion Contractures of Limited Joint Mobility of the Diabetic Hand Diabetes Care September 1997 20:1493-1495; doi:10.2337/diacare.20.9.1493

  2. Pasapula, Chandra

    • Higher Serum Sialic Acid in Women Than in Men With NIDDM: Possible Relevance to Increased Cardiovascular Risk in NIDDM Women Diabetes Care September 1997 20:1496; doi:10.2337/diacare.20.9.1496

  3. Pearce, Hilary

    • ACE Inhibitor Use Is Associated With Hospitalization for Severe Hypoglycemia in Patients With Diabetes Diabetes Care September 1997 20:1363-1367; doi:10.2337/diacare.20.9.1363

  4. Pellegrin, Maurizio De

    • Involvement of the Musculotendinous Apparatus in Flexion Contractures of Limited Joint Mobility of the Diabetic Hand Diabetes Care September 1997 20:1493-1495; doi:10.2337/diacare.20.9.1493

  5. Pérez, Antonio

    • Lack of Change of Lipoprotein(a) Levels by the Optimization of Glycemic Control With Insulin Therapy in NIDDM Patients Diabetes Care September 1997 20:1459-1461; doi:10.2337/diacare.20.9.1459

  6. Pickup, John C

    • Higher Serum Sialic Acid in Women Than in Men With NIDDM: Possible Relevance to Increased Cardiovascular Risk in NIDDM Women Diabetes Care September 1997 20:1496; doi:10.2337/diacare.20.9.1496

  7. Pincelli, Angela I

    • Involvement of the Musculotendinous Apparatus in Flexion Contractures of Limited Joint Mobility of the Diabetic Hand Diabetes Care September 1997 20:1493-1495; doi:10.2337/diacare.20.9.1493

  8. Porte, Daniel, Jr

    • Evidence That Plasma Leptin and Insulin Levels are Associated With Body Adiposity Via Different Mechanisms Diabetes Care September 1997 20:1476-1481; doi:10.2337/diacare.20.9.1476

  9. Prigeon, Ronald L

    • Evidence That Plasma Leptin and Insulin Levels are Associated With Body Adiposity Via Different Mechanisms Diabetes Care September 1997 20:1476-1481; doi:10.2337/diacare.20.9.1476

Q

  1. Qrdóñez-Llanos, Jordi

    • Lack of Change of Lipoprotein(a) Levels by the Optimization of Glycemic Control With Insulin Therapy in NIDDM Patients Diabetes Care September 1997 20:1459-1461; doi:10.2337/diacare.20.9.1459

R

  1. Ray, G Thomas

    • Excess Costs of Medical Care for Patients With Diabetes in a Managed Care Population Diabetes Care September 1997 20:1396-1402; doi:10.2337/diacare.20.9.1396

  2. Reaven, G M

    • Adherence of Mononuclear Cells to Endothelium In Vitro Is Increased in Patients With NIDDM Diabetes Care September 1997 20:1462-1465; doi:10.2337/diacare.20.9.1462

  3. Reece, E Albert

    • Longitudinal Study of Carbohydrate Metabolism in Healthy Obese Pregnant Women Diabetes Care September 1997 20:1470-1475; doi:10.2337/diacare.20.9.1470

  4. Rigla, Mercedes

    • Lack of Change of Lipoprotein(a) Levels by the Optimization of Glycemic Control With Insulin Therapy in NIDDM Patients Diabetes Care September 1997 20:1459-1461; doi:10.2337/diacare.20.9.1459

  5. Roberts, Graham A

    • Higher Serum Sialic Acid in Women Than in Men With NIDDM: Possible Relevance to Increased Cardiovascular Risk in NIDDM Women Diabetes Care September 1997 20:1496; doi:10.2337/diacare.20.9.1496

  6. Rowley, Merrill J

    • Evaluation of ICA512As in Combination With Other Islet Cell Autoantibodies at the Onset of IDDM Diabetes Care September 1997 20:1403-1407; doi:10.2337/diacare.20.9.1403

S

  1. Sanchez-Thorin, Juan Camilo

    • Retinopathy and Type 2 Diabetes Diabetes Care September 1997 20:1491-1492; doi:10.2337/diacare.20.9.1491b

  2. Sawanobori, Emi

    • Role of IGF Binding Protein- 1 in the Dawn Phenomenon and Glycemic Control in Children and Adolescents With IDDM Diabetes Care September 1997 20:1442-1447; doi:10.2337/diacare.20.9.1442

  3. Schellevis, F G

    • The Efficacy of Self-Monitoring of Blood Glucose in NIDDM subjects: A criteria-based literature review Diabetes Care September 1997 20:1482-1486; doi:10.2337/diacare.20.9.1482

  4. Schwartz, Michael W

    • Evidence That Plasma Leptin and Insulin Levels are Associated With Body Adiposity Via Different Mechanisms Diabetes Care September 1997 20:1476-1481; doi:10.2337/diacare.20.9.1476

  5. Selby, Joe V

    • Excess Costs of Medical Care for Patients With Diabetes in a Managed Care Population Diabetes Care September 1997 20:1396-1402; doi:10.2337/diacare.20.9.1396

  6. Service, F John

    • Dermal Interstitial Glucose as an Indicator of Ambient Glycemia Diabetes Care September 1997 20:1426-1429; doi:10.2337/diacare.20.9.1426

  7. Shahar, Eyal

    • Glycosylated Hemoglobin Level and Carotid Intimal-Medial Thickening in Nondiabetic Individuals: The Atherosclerosis Risk in Communities Study Diabetes Care September 1997 20:1454-1458; doi:10.2337/diacare.20.9.1454

  8. Silbershatz, Halit

    • NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study Diabetes Care September 1997 20:1388-1395; doi:10.2337/diacare.20.9.1388

  9. Sivan, Eyal

    • Longitudinal Study of Carbohydrate Metabolism in Healthy Obese Pregnant Women Diabetes Care September 1997 20:1470-1475; doi:10.2337/diacare.20.9.1470

  10. Strandberg, Timo E

    • Absolute Benefit From Cholesterol Lowering in Diabetic Patients With Coronary Heart Disease Diabetes Care September 1997 20:1495-1496; doi:10.2337/diacare.20.9.1495

  11. Stratton, Irene M

    • U.K. Prospective Diabetes Study 22: Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM Diabetes Care September 1997 20:1435-1441; doi:10.2337/diacare.20.9.1435

  12. Sugamori, Mark E

    • The Epidemiology of Diabetes in Pregnant Native Canadians: A risk profile Diabetes Care September 1997 20:1422-1425; doi:10.2337/diacare.20.9.1422

T

  1. Tam, Kar-Fai F

    • Maternal Serum Ferritin and Gestational Impaired Glucose Tolerance Diabetes Care September 1997 20:1368-1369; doi:10.2337/diacare.20.9.1368

  2. The Darts/Memo Collaboration

    • ACE Inhibitor Use Is Associated With Hospitalization for Severe Hypoglycemia in Patients With Diabetes Diabetes Care September 1997 20:1363-1367; doi:10.2337/diacare.20.9.1363

  3. Trimble, Elisabeth R

    • Treatment of Diabetic Ketoacidosis Using Normalization of Blood 3-Hydroxybutyrate Concentration as the Endpoint of Emergency Management: A randomized controlled study Diabetes Care September 1997 20:1347-1352; doi:10.2337/diacare.20.9.1347

  4. Tsao, P S

    • Adherence of Mononuclear Cells to Endothelium In Vitro Is Increased in Patients With NIDDM Diabetes Care September 1997 20:1462-1465; doi:10.2337/diacare.20.9.1462

  5. Tunçkale, Aydin

    • Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment Diabetes Care September 1997 20:1353-1356; doi:10.2337/diacare.20.9.1353

  6. Turner, Robert C

    • U.K. Prospective Diabetes Study 22: Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM Diabetes Care September 1997 20:1435-1441; doi:10.2337/diacare.20.9.1435

U

  1. U.K. Prospective Diabetes Study (UKPDS) Group

    • U.K. Prospective Diabetes Study 22: Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM Diabetes Care September 1997 20:1435-1441; doi:10.2337/diacare.20.9.1435

V

  1. Varasteh, B

    • Adherence of Mononuclear Cells to Endothelium In Vitro Is Increased in Patients With NIDDM Diabetes Care September 1997 20:1462-1465; doi:10.2337/diacare.20.9.1462

  2. Verge, Charles F

    • Evaluation of ICA512As in Combination With Other Islet Cell Autoantibodies at the Onset of IDDM Diabetes Care September 1997 20:1403-1407; doi:10.2337/diacare.20.9.1403

  3. Vitelli, Lori L

    • Glycosylated Hemoglobin Level and Carotid Intimal-Medial Thickening in Nondiabetic Individuals: The Atherosclerosis Risk in Communities Study Diabetes Care September 1997 20:1454-1458; doi:10.2337/diacare.20.9.1454

W

  1. Walsh, P

    • The Use of Biothesiometry to Detect Neuropathy in Children and Adolescents With IDDM Diabetes Care September 1997 20:1448-1453; doi:10.2337/diacare.20.9.1448

  2. Wawryk, Andrew M

    • Power Spectral Analysis of Heart Rate Variability in Children and Adolescents With IDDM Diabetes Care September 1997 20:1416-1421; doi:10.2337/diacare.20.9.1416

  3. Whalen, Elaine A

    • The Epidemiology of Diabetes in Pregnant Native Canadians: A risk profile Diabetes Care September 1997 20:1422-1425; doi:10.2337/diacare.20.9.1422

  4. Wiggam, M Ivan

    • Treatment of Diabetic Ketoacidosis Using Normalization of Blood 3-Hydroxybutyrate Concentration as the Endpoint of Emergency Management: A randomized controlled study Diabetes Care September 1997 20:1347-1352; doi:10.2337/diacare.20.9.1347

  5. Wilson, Peter W

    • NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study Diabetes Care September 1997 20:1388-1395; doi:10.2337/diacare.20.9.1388

  6. Wise, Steven D

    • Dermal Interstitial Glucose as an Indicator of Ambient Glycemia Diabetes Care September 1997 20:1426-1429; doi:10.2337/diacare.20.9.1426

  7. Wolf, Philip A

    • NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study Diabetes Care September 1997 20:1388-1395; doi:10.2337/diacare.20.9.1388

Y

  1. Yago, Hisashi

    • Effects of Glycemic Control on Plasma 3-Deoxyglucosone Levels in NIDDM Patients Diabetes Care September 1997 20:1466-1469; doi:10.2337/diacare.20.9.1466

  2. Yoshino, Gen

    • Insulin Responses to Oral Glucose During 4-Year Treatment With Nifedipine Retard in Hypertensive Patients With and Without NIDDM Diabetes Care September 1997 20:1491; doi:10.2337/diacare.20.9.1491a

Z

  1. Zhang, Danya

    • Excess Costs of Medical Care for Patients With Diabetes in a Managed Care Population Diabetes Care September 1997 20:1396-1402; doi:10.2337/diacare.20.9.1396

  2. Zimmet, Paul Z

    • Evaluation of ICA512As in Combination With Other Islet Cell Autoantibodies at the Onset of IDDM Diabetes Care September 1997 20:1403-1407; doi:10.2337/diacare.20.9.1403

  3. Zinman, Bernard

    • Serum Immunoreactive Leptin Concentrations in a Canadian Aboriginal Population With High Rates of NIDDM Diabetes Care September 1997 20:1408-1415; doi:10.2337/diacare.20.9.1408

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement